Kimihiko Fujisawa
Oprichter bij Aqumen Biopharmaceuticals KK
Actieve functies van Kimihiko Fujisawa
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Aqumen Biopharmaceuticals KK
 Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Directeur/Bestuurslid | 06-08-2009 | - |
| Oprichter | 04-05-2010 | - |
Loopbaan van Kimihiko Fujisawa
Opleiding van Kimihiko Fujisawa
| Kyushu University | Doctorate Degree |
Statistieken
Internationaal
| Japan | 3 |
Operationeel
| Director/Board Member | 1 |
| Founder | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Aqumen Biopharmaceuticals KK
Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Health Technology |
- Beurs
- Insiders
- Kimihiko Fujisawa
- Ervaring
